MGD013
Showing 1 - 19 of 19
Advanced Hepatocellular Carcinoma (HCC) Trial in Hong Kong (MGD013 monotherapy, MGD013 in combination with Brivanib Alaninate)
Terminated
- Advanced Hepatocellular Carcinoma (HCC)
- MGD013 monotherapy
- MGD013 in combination with Brivanib Alaninate
-
Hong Kong, Hong Kong, ChinaPrince of Wales Hospital
Jun 8, 2022
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial (enoblituzumab, MGA012, MGD013)
Withdrawn
- Head and Neck Cancer
- Squamous Cell Carcinoma of Head and Neck
- enoblituzumab
- +2 more
- (no location specified)
Feb 4, 2022
Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)
Terminated
- Unresectable, Recurrent or Metastatic Melanoma
- Untreated Mucosal or Acral Lentiginous Melanoma
- MGD013
-
Beijing, Beijing, China
- +12 more
Apr 12, 2022
Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,
Active, not recruiting
- Gastric Cancer
- +2 more
- margetuximab
- +4 more
-
Scottsdale, Arizona
- +72 more
Aug 24, 2022
Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Enoblituzumab, Retifanlimab,
Recruiting
- Head and Neck Cancer
- +2 more
- Enoblituzumab
- +2 more
-
Baltimore, Maryland
- +41 more
May 16, 2022
Dry Eye Syndromes Trial in Kansas City (Lifitegrast Ophthalmic, Systane Free, Lipiflow)
Active, not recruiting
- Dry Eye Syndromes
- Lifitegrast Ophthalmic
- +2 more
-
Kansas City, Missourijoseph Tauber
Oct 25, 2022
Meibomian Gland Dysfunction, Dry Eye Syndromes, Ocular Surface Disease Trial in San Antonio (Zocular Eyelid System Treatment)
Completed
- Meibomian Gland Dysfunction
- +2 more
- Zocular Eyelid System Treatment
-
San Antonio, TexasRosenberg School of Optometry
Jul 13, 2022
Meibomian Gland Dysfunction Trial in Kowloon, Shatin (device, behavioral, drug)
Recruiting
- Meibomian Gland Dysfunction
- Vectored thermal pulsation (VTP) therapy
- +3 more
-
Kowloon, Hong Kong
- +3 more
Nov 26, 2022
The Carotid Artery Multi-modality Imaging Prognostic Study
Recruiting
- Carotid Artery Diseases
- +2 more
-
Pisa, Tuscany, ItalyAzienda Ospedaliero Universitaria Pisana
Nov 6, 2022
Dry Eye, Neuropathic Eye Pain, Ocular Microbiome Trial in San Francisco (Azithromycin Oral Product, Placebo Oral)
Recruiting
- Dry Eye
- +3 more
- Azithromycin Oral Product
- Placebo Oral
-
San Francisco, CaliforniaUniversity of California San Francisco
Jan 29, 2021
Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)
Recruiting
- Exudative Macular Degeneration
- Wet Age-related Macular Degeneration
- Doxycycline Hyclate
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics Department of Ophthalmolo
Apr 5, 2022
Meibomian Gland Dysfunction, Dry Eye Disease, Evaporative Dry Eye Trial in Sao Paulo (Jett Plasma Medical Lift, Mechanical
Unknown status
- Meibomian Gland Dysfunction
- +4 more
- Jett Plasma Medical Lift
- Mechanical Debridement
-
Sao Paulo, SP, Brazil
- +1 more
Oct 24, 2020
Anterior Blepharitis Trial in Los Angeles (Microblepharoexfoliative procedure with BlephEx™, Eyelid cleansing with eyelid wipes
Terminated
- Anterior Blepharitis
- Microblepharoexfoliative procedure with BlephEx™
- +2 more
-
Los Angeles, CaliforniaStein Eye Institute, UCLA
Jan 27, 2021
Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma Trial in Kota Bharu (Visual rehabilitation module: navigation and
Recruiting
- Primary Open Angle Glaucoma
- Primary Angle Closure Glaucoma
- Visual rehabilitation module: navigation and mobility
- +2 more
-
Kota Bharu, Kelantan, MalaysiaUniversiti Sains Malaysia
Feb 2, 2021
Meibomian Gland Dysfunction and Tear Cytokines After Cataract
Completed
- Cataract
-
Seoul, Korea, Republic ofDepartment of Ophthalmology
Jan 23, 2017
Dry Eye Syndromes, Meibomian Gland Dysfunction Trial (Systane Balance eye drops, Systane Contacts eye drops, saline)
Completed
- Dry Eye Syndromes
- Meibomian Gland Dysfunction
- Systane Balance eye drops
- +2 more
- (no location specified)
Nov 2, 2016
Dry Eye Syndrome, Healthy Trial in Rochester (Environmental Chamber Condition Change Intervention)
Terminated
- Dry Eye Syndrome
- Healthy
- Environmental Chamber Condition Change Intervention
-
Rochester, New YorkFlaum Eye Institute at the University of Rochester
Sep 17, 2015
Meibomian Gland Dysfunction Trial in Singapore (Blephasteam, EyeGiene, Hot compresses)
Completed
- Meibomian Gland Dysfunction
- Blephasteam
- +2 more
-
Singapore, SingaporeSingapore National Eye Centre/ Singapore Eye Research Institute
Jun 9, 2014